Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Non Operating Income: 2011-2025

Historic Non Operating Income for Capricor Therapeutics (CAPR) over the last 13 years, with Sep 2025 value amounting to $1.7 million.

  • Capricor Therapeutics' Non Operating Income rose 278.11% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 64.04%. This contributed to the annual value of $2.1 million for FY2024, which is 17.17% up from last year.
  • Capricor Therapeutics' Non Operating Income amounted to $1.7 million in Q3 2025, which was up 189.74% from $591,354 recorded in Q2 2025.
  • Over the past 5 years, Capricor Therapeutics' Non Operating Income peaked at $1.7 million during Q3 2025, and registered a low of $9,165 during Q1 2021.
  • Its 3-year average for Non Operating Income is $619,272, with a median of $496,598 in 2023.
  • As far as peak fluctuations go, Capricor Therapeutics' Non Operating Income soared by 9,582.22% in 2021, and later crashed by 72.14% in 2022.
  • Capricor Therapeutics' Non Operating Income (Quarterly) stood at $189,118 in 2021, then skyrocketed by 82.65% to $345,433 in 2022, then surged by 50.30% to $519,203 in 2023, then increased by 11.95% to $581,238 in 2024, then skyrocketed by 278.11% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $591,354 for Q2 2025, and $581,238 during Q4 2024.